The FDA is considering phasing out animal testing for drug development, marking a significant step towards modernizing outdated regulations.

AJA001, a botanical drug for autism spectrum disorder (ASD), showed positive Phase 1 trial results. Phase 2 trials are set for mid-2025. AJA

该产品最早由北美土著居民使用，自20世纪30年代以来在美国被用于缓解疼痛，早于美国食品药品监督管理局（FDA）的成立。它是一种由单一植物制成的植物性溶液，目前在美国市场上作为处方药销售。方案1-投资交换产品的美国股权。方案2-出让中国地区产品开发销售权。

Many early pharmaceutical drugs, including codeine, quinine, and digoxin, were derived from plants. While traditional drug development...

Fermentation is an important concoction technique for botanical drugs. Fermentation transforms and enhances the active ingredients of botani

Route of Administration: subcutaneous, intramuscular, and intra-articular administration Current Status: The product, first used by...

As the top 20 biopharma companies collectively have a staggering $180 billion in sales at risk due to patent expiration slated to occur arou

The TCM qiliqiangxin reduces hospitalization for heart failure and cardiovascular death in patients with heart fail

A plant-based, oral delivery of proinsulin lowers the risk of hypoglycemia when compared to current diabetes treatments, according to a new

British American Tobacco (BAT), a major player in the global cigarette market, made a surprising move by announcing a significant...

FDA has granted approval for FILSUVEZ®, a topical gel containing birch triterpenes, designed to address the treatment of partial thickness w

The American Botanical Drug Association (ABDA) is advancing an unprecedented initiative through its affiliated analytical laboratory,...

Maye Musk, the renowned model, dietitian, and mother of entrepreneur Elon Musk, added star power to a high-profile entrepreneur gathering by

Napo Pharmaceuticals's pivotal phase 3 OnTarget trial for prophylaxis of diarrhea in adult cancer patients is a 12-week trial targets cancer

In what is being hailed as a major advancement in the field of burn care, the U.S. Food and Drug Administration (FDA) has recently...

In patients with ST-segment elevation myocardial infarction (STEMI), the traditional Chinese medicine Tongxinluo, as an adjunctive therapy

At the forefront of groundbreaking research, Coacillium, a plant-based drug developed by Legacy Healthcare, has emerged as a potential...

Abstract: botanical drug clinical trials registered at ClinicalTrial.gov were analyzed. Trends in current trials were discovered and guide f

Alphyn Biologics, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics, released interim results...

Sinoveda is a health brand that is bringing innovative, herbally-based precision to drug discovery. The company's research team, led by...